Revenue | ₹6.50Cr |
Net Profits | ₹1.03Cr |
Net Profit Margins | 15.85% |
Shukra Pharmaceuticals Ltd’s revenue jumped 66.67% since last year same period to ₹6.50Cr in the Q1 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated -55.9% fall in its revenue since last 3-months.
Shukra Pharmaceuticals Ltd’s net profit jumped 110.2% since last year same period to ₹1.03Cr in the Q1 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated -80.89% fall in its net profits since last 3-months.
Shukra Pharmaceuticals Ltd’s net profit margin jumped 26.12% since last year same period to 15.85% in the Q1 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated -56.67% fall in its net profit margins since last 3-months.
The revenue for Shukra Pharmaceuticals Ltd in the Q1 results 2025 was ₹6.50Cr.
The net profit for Shukra Pharmaceuticals Ltd in the Q1 results 2025 was ₹1.03Cr.
The net profit margin for Shukra Pharmaceuticals Ltd in the Q1 results 2025 was 15.85%.
The revenue for Shukra Pharmaceuticals Ltd in the Q1 results 2024 was ₹3.90Cr.
The net profit for Shukra Pharmaceuticals Ltd in the Q1 results 2024 was ₹0.49Cr.
The net profit margin for Shukra Pharmaceuticals Ltd in the Q1 results 2024 was 12.56%.